NATH BIOGENES (INDIA)
Back to Income Statement
|
NATH BIOGENES (INDIA) Last 5 Year Total Expenditure History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2013 | |
|---|---|---|---|---|---|
| Total Expenditure | ₹315 Cr | ₹283 Cr | ₹252 Cr | ₹241 Cr | ₹118 Cr |
What is the latest Total Expenditure of NATH BIOGENES (INDIA) ?
| Year | Total Expenditure |
|---|---|
| Mar2025 | ₹315 Cr |
| Mar2024 | ₹283 Cr |
| Mar2023 | ₹252 Cr |
| Mar2022 | ₹241 Cr |
| Mar2013 | ₹118 Cr |
How is Total Expenditure of NATH BIOGENES (INDIA) Trending?
| Years | Total Expenditure | % Change | |
|---|---|---|---|
| Mar2025 | ₹315 Cr | 11.42 | |
| Mar2024 | ₹283 Cr | 12.00 | |
| Mar2023 | ₹252 Cr | 4.66 | |
| Mar2022 | ₹241 Cr | 104.70 | |
| Mar2013 | ₹118 Cr | - | |
Compare Total Expenditure of peers of NATH BIOGENES (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATH BIOGENES (INDIA) | ₹317.0 Cr | -1% | -4.8% | -12.8% | Stock Analytics | |
| BOMBAY BURMAH TRADING CORPORATION | ₹12,770.3 Cr | -5.4% | -4.2% | -31% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹5,503.0 Cr | 7.1% | 1.1% | 15.6% | Stock Analytics | |
| VENKYS (INDIA) | ₹1,912.2 Cr | -0.2% | -7.4% | -23.1% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹1,229.5 Cr | -4.1% | -3.1% | -27.1% | Stock Analytics | |
| INDO US BIOTECH | ₹258.5 Cr | -0.8% | -0.3% | -48.8% | Stock Analytics | |
NATH BIOGENES (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATH BIOGENES (INDIA) | -1% |
-4.8% |
-12.8% |
| SENSEX | 1.6% |
2.7% |
6.3% |
You may also like the below Video Courses